In addition, patients in cluster 2 had significantly higher levels of CXCL14, SFRP4, and MGPI score, and lower level of CD38 than those in cluster 1 for PCa patients from the TCGA database (Figure 2L) and GSE116918 (17) (Figure 2M). The gene discussed is SFRP4; the disease is posterior cortical atrophy.